September 9, 2009
Title: Inhibition of Novel Molecular Targets of Prostaglandin Formation for Antitumor Activity
Speaker: Emmanuelle Meuillet, Ph.D., Assistant Professor of Nutrition, University of Arizona, Tucson, AZ

October 7, 2009
Title: Targeting Sphingolipid Metabolism – Therapeutic Approaches in Prostate and Pancreatic Cancer and Acute Myeloid Leukemia
Speaker: Myles Cabot, Ph.D., Department of Experimental Therapeutics, John Wayne Cancer Institute. Santa Monica, CA

February 3, 2010
Title: To Be Determined
Speaker: C. Parker Gibbs, M.D., Associate Professor, Orthopaedic Oncology, University of Florida, Gainesville, FL

March 3, 2010
Title: Maximizing the Therapeutic Impact of KIT/PDGFR Inhibitors
Speaker: Jonathan Fletcher, M.D., Associate Professor, Dept of Pathology and Harvard Medical School, Boston, MA

March 31, 2010
Title: Identifying microRNA-regulated Gene Networks
Speaker: Judy Lieberman, M.D., Ph.D., Senior Investigator, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston; Professor of Pediatrics, Harvard Medial School, Boston, MA

April 14, 2010
Title: Complex Responses to DNA Damaging Agents
Speaker: Leona Sampson, Ph.D., Professor of Toxicology and Biological Engineering, Director, Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA

April 28, 2010
Title: To Be Determined
Speaker: Lisa Boardman, M.D., Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

May 12, 2010
Title: Epithelial Interactions: Cadherin Signaling and the Acting Cytoskeleton
Speaker: Alpha Yap, Ph.D., Head, Division of Molecular Cell Biology, Institute for Molecular Bioscience, University of Queensland, Queensland, Australia